Inhibition of Inflammation and iNOS Improves Lymphatic Function in Obesity

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Torrisi, Jeremy S ^a   Hespe, Geoffrey E ^a   Cuzzone, Daniel A ^a   Savetsky, Ira L ^a   Nitti, Matthew D ^a   Gardenier, Jason C ^a   Nores, Gabriela D García ^a   Jowhar, Dawit ^a   Kataru, Raghu P ^a   Mehrara, Babak J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; TACROLIMUS;

ANIMAL; C57BL MOUSE; CELL MOTION; COMPLICATION; DENDRITIC CELL; DRUG EFFECTS; ENZYMOLOGY; FEEDING BEHAVIOR; INFLAMMATION; KNOCKOUT MOUSE; LIPID DIET; LYMPH NODE; LYMPH VESSEL; METABOLISM; MOUSE MUTANT; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; TOPICAL DRUG ADMINISTRATION; TRANSPORT AT THE CELLULAR LEVEL;

ADMINISTRATION, TOPICAL; ANIMALS; BIOLOGICAL TRANSPORT; CELL MOVEMENT; DENDRITIC CELLS; DIET, HIGH-FAT; FEEDING BEHAVIOR; INFLAMMATION; LYMPH NODES; LYMPHATIC VESSELS; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, OBESE; NITRIC OXIDE SYNTHASE TYPE II; OBESITY; TACROLIMUS;

EID: 84955511796     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep19817     Document Type: Article

References (56)

1. Lim, H. Y. et al. Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration. The American journal of pathology 175, 1328-1337 (2009).
2. Blum, K. S. et al. Chronic high-fat diet impairs collecting lymphatic vessel function in mice. PLoS One 9, e94713 (2014).
3. Weitman, E. S. et al. Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes. PloS one 8, e70703 (2013).
4. DiSipio, T., Rye, S., Newman, B. & Hayes, S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. The Lancet. Oncology 14, 500-515 (2013).
5. Greene, A. K., Grant, F. D. & Slavin, S. A. Lower-extremity lymphedema and elevated body-mass index. N Engl J Med 366, 2136-2137 (2012).
6. Arngrim, N., Simonsen, L., Holst, J. J. & Bulow, J. Reduced adipose tissue lymphatic drainage of macromolecules in obese subjects: a possible link between obesity and local tissue inflammation? International journal of obesity 37, 748-750 (2013).
7. Savetsky, I. L. et al. Obesity increases inflammation and impairs lymphatic function in a mouse model of lymphedema. Am J Physiol Heart Circ Physiol 307, H165-172 (2014).
8. Gregor, M. F. & Hotamisligil, G. S. Inflammatory mechanisms in obesity. Annu Rev Immunol 29, 415-445 (2011).
9. Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860-867 (2006).
10. Kintscher, U. et al. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 28, 1304-1310 (2008).
11. Nishimura, S. et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15, 914-920 (2009).
12. Winer, S. et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 15, 921-929 (2009).
13. Wu, H. et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 115, 1029-1038 (2007).
14. Yang, H. et al. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol 185, 1836-1845 (2010).
15. Han, J. M. & Levings, M. K. Immune regulation in obesity-associated adipose inflammation. Journal of immunology 191, 527-532 (2013).
16. Iantorno, M. et al. Obesity, inflammation and endothelial dysfunction. J Biol Regul Homeost Agents 28, 169-176 (2014).
17. Louie, S. M., Roberts, L. S. & Nomura, D. K. Mechanisms linking obesity and cancer. Biochimica et biophysica acta 1831, 1499-1508 (2013).
18. Savetsky, I. L. et al. Lymphatic Function Regulates Contact Hypersensitivity Dermatitis in Obesity. The Journal of investigative dermatology. doi: 10.1038/jid.2015.283 (2015).
19. Vuorio, T. et al. Lymphatic vessel insufficiency in hypercholesterolemic mice alters lipoprotein levels and promotes atherogenesis. Arteriosclerosis, thrombosis, and vascular biology 34, 1162-1170 (2014).
20. Veronique, A. & Ying, L. H. Emerging role of lymphatic vessels in reverse cholesterol transport. Aging 5, 390-391 (2013).
21. Kahn, M. L. & Rader, D. J. Lymphatics as a new active player in reverse cholesterol transport. Cell metabolism 17, 627-628 (2013).
22. Kataru, R. P. et al. T lymphocytes negatively regulate lymph node lymphatic vessel formation. Immunity 34, 96-107 (2011).
23. Clavin, N. W. et al. TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair. American journal of physiology. Heart and circulatory physiology 295, H2113-2127 (2008).
24. Oka, M. et al. Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis. Blood 111, 4571-4579 (2008).
25. Platt, A. M. & Randolph, G. J. Dendritic cell migration through the lymphatic vasculature to lymph nodes. Advances in immunology 120, 51-68 (2013).
26. Liao, S. et al. Impaired lymphatic contraction associated with immunosuppression. Proc Natl Acad Sci USA 108, 18784-18789 (2011).
27. Mattila, J. T. & Thomas, A. C. Nitric oxide synthase: non-canonical expression patterns. Frontiers in immunology 5, 478 (2014).
28. Thomsen, L. L. et al. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer research 57, 3300-3304 (1997).
29. Wang, J. et al. Inhibition of poly (ADP-ribose) polymerase and inducible nitric oxide synthase protects against ischemic myocardial damage by reduction of apoptosis. Molecular medicine reports 11, 1768-1776 (2015).
30. Nemec, A. et al. Systemic use of selective iNOS inhibitor 1400W or non-selective NOS inhibitor l-NAME differently affects systemic nitric oxide formation after oral Porphyromonas gingivalis inoculation in mice. Archives of oral biology 55, 509-514 (2010).
31. Mauricio, M. D., Aldasoro, M., Ortega, J. & Vila, J. M. Endothelial dysfunction in morbid obesity. Current pharmaceutical design 19, 5718-5729 (2013).
32. Prieto, D., Contreras, C. & Sanchez, A. Endothelial dysfunction, obesity and insulin resistance. Current vascular pharmacology 12, 412-426 (2014).
33. Berg, A. H. & Scherer, P. E. Adipose tissue, inflammation, and cardiovascular disease. Circulation research 96, 939-949 (2005).
34. Avraham, T. et al. Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema. FASEB J 27, 1114-1126 (2013).
35. Zampell, J. C. et al. CD4(+) cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis. PloS one 7, e49940 (2012).
36. Cromer, W. E. et al. The effects of inflammatory cytokines on lymphatic endothelial barrier function. Angiogenesis 17, 395-406 (2014).
37. Shin, K. et al. TH2 cells and their cytokines regulate formation and function of lymphatic vessels. Nat Commun 6, 6196 (2015).
38. Kataru, R. P. et al. Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 113, 5650-5659 (2009).
39. Tinahones, F. J. et al. Obesity-associated insulin resistance is correlated to adipose tissue vascular endothelial growth factors and metalloproteinase levels. BMC physiology 12, 4 (2012).
40. Wada, H. et al. Distinct characteristics of circulating vascular endothelial growth factor-a and C levels in human subjects. PloS one 6, e29351 (2011).
41. Karaman, S. et al. Blockade of VEGF-C and VEGF-D modulates adipose tissue inflammation and improves metabolic parameters under high-fat diet. Molecular metabolism 4, 93-105 (2015).
42. Dutta, S. & Ahmad, Y. The efficacy and safety of tacrolimus in rheumatoid arthritis. Therapeutic advances in musculoskeletal disease 3, 283-291 (2011).
43. Kelly, P. A., Burckart, G. J. & Venkataramanan, R. Tacrolimus: a new immunosuppressive agent. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 52, 1521-1535 (1995).
44. Zawieja, S. D. et al. Impairments in the intrinsic contractility of mesenteric collecting lymphatics in a rat model of metabolic syndrome. American journal of physiology. Heart and circulatory physiology 302, H643-653 (2012).
45. Koppula, S., Kumar, H., Kim, I. S. & Choi, D. K. Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson's disease. Mediators of inflammation 2012, 823902 (2012).
46. Gashev, A. A., Davis, M. J. & Zawieja, D. C. Inhibition of the active lymph pump by flow in rat mesenteric lymphatics and thoracic duct. J Physiol 540, 1023-1037 (2002).
47. Gasheva, O. Y., Zawieja, D. C. & Gashev, A. A. Contraction-initiated NO-dependent lymphatic relaxation: a self-regulatory mechanism in rat thoracic duct. The Journal of physiology 575, 821-832 (2006).
48. Gasheva, O. Y., Knippa, K., Nepiushchikh, Z. V., Muthuchamy, M. & Gashev, A. A. Age-related alterations of active pumping mechanisms in rat thoracic duct. Microcirculation 14, 827-839 (2007).
49. Bohlen, H. G., Wang, W., Gashev, A., Gasheva, O. & Zawieja, D. Phasic contractions of rat mesenteric lymphatics increase basal and phasic nitric oxide generation in vivo. American journal of physiology. Heart and circulatory physiology 297, H1319-1328 (2009).
50. Scallan, J. P. & Davis, M. J. Genetic removal of basal nitric oxide enhances contractile activity in isolated murine collecting lymphatic vessels. The Journal of physiology 591, 2139-2156 (2013).
51. Aldrich, M. B. & Sevick-Muraca, E. M. Cytokines are systemic effectors of lymphatic function in acute inflammation. Cytokine 64, 362-369 (2013).
52. Scallan, J. P., Hill, M. A. & Davis, M. J. Lymphatic vascular integrity is disrupted in type 2 diabetes due to impaired nitric oxide signalling. Cardiovascular research 107, 89-97 (2015).
53. Robinson, H. A. et al. Non-invasive optical imaging of the lymphatic vasculature of a mouse. Journal of visualized experiments: JoVE, e4326, doi: 10.3791/4326 (2013).
54. Davies-Venn, C. A. et al. Albumin-binding domain conjugate for near-infrared fluorescence lymphatic imaging. Molecular imaging and biology: MIB: the official publication of the Academy of Molecular Imaging 14, 301-314 (2012).
55. Sharma, R. et al. Quantitative imaging of lymph function. Am J Physiol Heart Circ Physiol 292, H3109-3118 (2007).
56. Avraham, T. et al. Blockade of transforming growth factor-beta1 accelerates lymphatic regeneration during wound repair. The American journal of pathology 177, 3202-3214 (2010).